SG11201508796SA - Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method - Google Patents
Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the methodInfo
- Publication number
- SG11201508796SA SG11201508796SA SG11201508796SA SG11201508796SA SG11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA
- Authority
- SG
- Singapore
- Prior art keywords
- stem cell
- induced pluripotent
- pluripotent stem
- produced
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1369—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2013/009845 WO2015064795A1 (en) | 2013-11-01 | 2013-11-01 | Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201508796SA true SG11201508796SA (en) | 2015-11-27 |
Family
ID=53004383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201508796SA SG11201508796SA (en) | 2013-11-01 | 2013-11-01 | Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9938504B2 (en) |
| EP (1) | EP3064572B1 (en) |
| JP (1) | JP6700175B2 (en) |
| CN (1) | CN105264066B (en) |
| CY (1) | CY1123057T1 (en) |
| DK (1) | DK3064572T3 (en) |
| ES (1) | ES2790669T3 (en) |
| HR (1) | HRP20200701T1 (en) |
| HU (1) | HUE049567T2 (en) |
| LT (1) | LT3064572T (en) |
| PL (1) | PL3064572T3 (en) |
| PT (1) | PT3064572T (en) |
| RS (1) | RS60200B1 (en) |
| SG (1) | SG11201508796SA (en) |
| SI (1) | SI3064572T1 (en) |
| WO (1) | WO2015064795A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101592401B1 (en) * | 2014-06-13 | 2016-02-05 | 주식회사 비비에이치씨 | Method for Preparing patient-specific Induced Pluripotency Stem Cell from adipose-derived Mesenchymal Stem Cell and Production thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100697326B1 (en) * | 2005-12-02 | 2007-03-20 | 재단법인서울대학교산학협력재단 | Multipotent Adult Stem Cells Having an Ability of Oct4 Expression Derived from Umbilical Cord Blood and Method for Preparing the Same |
| KR100792184B1 (en) * | 2006-05-12 | 2008-01-07 | 재단법인서울대학교산학협력재단 | Mutipotent Adult Stem Cell Derived from Canine Umbilical Cord Blood, Placenta and Canine Fetus Heart, Method for Preparing the Same and Cellular Therapeutics Containing the Same |
| US20100135970A1 (en) * | 2006-10-27 | 2010-06-03 | Caritas St. Elizabeth Medical Center Of Boston, In | Methods for Reprogramming Adult Somatic Cells and Uses Thereof |
| CN101748096B (en) * | 2008-12-17 | 2013-03-13 | 北京汉氏联合生物技术有限公司 | Sub totipotential stem cell and preparation method and application thereof |
| KR101016761B1 (en) | 2009-02-26 | 2011-02-25 | 부경대학교 산학협력단 | Ecklonia cava Kjellman extracts having skin whitening activity |
| KR100950195B1 (en) * | 2009-03-20 | 2010-03-29 | 서울대학교산학협력단 | Method for isolation of umbilical cord blood derived-pluripotent stem cell expressing znf281 |
| WO2010114572A1 (en) * | 2009-03-31 | 2010-10-07 | The Board Of Regents Of The University Of Texas System | Isolation of human umbilical cord blood-derived mesenchymal stem cells |
| JP2014133703A (en) * | 2011-03-30 | 2014-07-24 | Clio Inc | Composition for cell therapy for allotransplant including ssea-3 positive pluripotent stem cell that can be isolated from biological tissue |
| WO2011037301A1 (en) * | 2009-09-22 | 2011-03-31 | 서울대학교병원 | Method for derivation of pluripotent stem cells from adult cells and pluripotent stem cells produced by method |
| KR20120040488A (en) | 2010-10-19 | 2012-04-27 | 충남대학교산학협력단 | Cosmetic compositions containing phlorotannins from ecklonia stolonifera and ecklonia cave extract |
| WO2012080842A1 (en) * | 2010-12-17 | 2012-06-21 | Biolamina Ab | Recombinant laminin-521 |
| KR101887956B1 (en) | 2011-08-10 | 2018-08-13 | (주)아모레퍼시픽 | Composition for skin lightening comprising extract of Ecklonia cava treated by enzyme |
| KR101408106B1 (en) * | 2011-12-30 | 2014-06-19 | 박영준 | Compositions for Enhancing Differentiation of Stem Cell |
| KR101542849B1 (en) | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | Method for Differentiating Pluripotency Stem Cell Induced from Mesenchymal Stem Cell into Hepatocyte |
| KR101542848B1 (en) | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | Method for Differentiating Pluripotency Stem Cell Induced from Mesenchymal Stem Cell into Osteoblast |
| KR101542847B1 (en) | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | Method for Differentiating Pluripotency Stem Cell Induced from Mesenchymal Stem Cell into Neuron |
| KR101542846B1 (en) | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | Method for Differentiating Pluripotency Stem Cell Induced from Mesenchymal Stem Cell into Chondrocyte |
| KR101542850B1 (en) | 2013-11-01 | 2015-08-10 | 주식회사 비비에이치씨 | Method for Differentiating Pluripotency Stem Cell Induced from Mesenchymal Stem Cell into Adipocyte |
| KR101699761B1 (en) | 2014-05-23 | 2017-01-25 | 주식회사 비비에이치씨 | Method for Preparing Induced Pluripotency Stem Cell from Mesenchymal Stem Cell Using Phlorotannin Fraction |
| KR101592401B1 (en) | 2014-06-13 | 2016-02-05 | 주식회사 비비에이치씨 | Method for Preparing patient-specific Induced Pluripotency Stem Cell from adipose-derived Mesenchymal Stem Cell and Production thereof |
-
2013
- 2013-11-01 SG SG11201508796SA patent/SG11201508796SA/en unknown
- 2013-11-01 DK DK13896647.8T patent/DK3064572T3/en active
- 2013-11-01 WO PCT/KR2013/009845 patent/WO2015064795A1/en active Application Filing
- 2013-11-01 US US14/783,893 patent/US9938504B2/en active Active
- 2013-11-01 PL PL13896647T patent/PL3064572T3/en unknown
- 2013-11-01 JP JP2016521177A patent/JP6700175B2/en active Active
- 2013-11-01 RS RS20200468A patent/RS60200B1/en unknown
- 2013-11-01 SI SI201331714T patent/SI3064572T1/en unknown
- 2013-11-01 PT PT138966478T patent/PT3064572T/en unknown
- 2013-11-01 LT LTEP13896647.8T patent/LT3064572T/en unknown
- 2013-11-01 EP EP13896647.8A patent/EP3064572B1/en active Active
- 2013-11-01 HU HUE13896647A patent/HUE049567T2/en unknown
- 2013-11-01 ES ES13896647T patent/ES2790669T3/en active Active
- 2013-11-01 CN CN201380076537.XA patent/CN105264066B/en active Active
-
2020
- 2020-04-27 CY CY20201100378T patent/CY1123057T1/en unknown
- 2020-04-30 HR HRP20200701TT patent/HRP20200701T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6700175B2 (en) | 2020-05-27 |
| CY1123057T1 (en) | 2021-10-29 |
| EP3064572A1 (en) | 2016-09-07 |
| ES2790669T3 (en) | 2020-10-28 |
| HUE049567T2 (en) | 2020-10-28 |
| PT3064572T (en) | 2020-05-07 |
| US20160230146A1 (en) | 2016-08-11 |
| RS60200B1 (en) | 2020-06-30 |
| EP3064572A4 (en) | 2017-03-22 |
| HRP20200701T1 (en) | 2020-12-11 |
| US9938504B2 (en) | 2018-04-10 |
| SI3064572T1 (en) | 2020-08-31 |
| PL3064572T3 (en) | 2020-07-13 |
| CN105264066B (en) | 2021-06-11 |
| DK3064572T3 (en) | 2020-05-04 |
| WO2015064795A1 (en) | 2015-05-07 |
| EP3064572B1 (en) | 2020-02-12 |
| JP2016521990A (en) | 2016-07-28 |
| CN105264066A (en) | 2016-01-20 |
| LT3064572T (en) | 2020-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222200A1 (en) | Method for preparing pluripotent stem cells | |
| HK1219050A1 (en) | Immunoprotective primary mesenchymal stem cells and methods | |
| HK1220487A1 (en) | Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method | |
| LT3064575T (en) | Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into hepatocyte | |
| PT3064573T (en) | Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into neuron | |
| PT3064574T (en) | Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into chondrocyte | |
| LT3156481T (en) | Method for manufacturing induced pluripotent stem cells from adipose-derived mesenchymal stem cells and induced pluripotent stem cells manufactured by same method | |
| EP3015551A4 (en) | Screening process for pluripotent stem cell propagation promoting factor | |
| PT3036321T (en) | Process for producing multipotent stem cells and progenitors | |
| PL3064571T3 (en) | Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into osteoblast | |
| SG11201508796SA (en) | Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method | |
| EP3040416A4 (en) | Method for producing induced pluripotent stem cells |